Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The aims of this protocol are:
1. To study the safety and tolerability of the combination of etanercept and gemcitabine in
patients with advanced pancreatic cancer:
2. To estimate the anti-tumor effect as measured by the proportion of patients free of
disease-progression at six months after treatment initiation.